MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.atherosclerosis.2016.07.897

Медицинская библиотека · Atherosclerosis · 2016

Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.

Chruściel Piotr, Sahebkar Amirhossein, Rembek-Wieliczko Magdalena, Serban Maria-Corina, Ursoniu Sorin, Mikhailidis Dimitri P, Jones Steven R, Mosteoru Svetlana, Blaha Michael J, Martin Seth S, Rysz Jacek, Toth Peter P, Lip Gregory Y H, Pencina Michael J, Ray Kausik K, Banach Maciej, Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group

СтатьяМетаанализСистематический обзорПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: The effect of statin therapy on plasma adiponectin levels has not been conclusively studied. Therefore, we aimed to evaluate this effect through a systematic review and meta-analysis of available randomized controlled trials (RCTs).

METHODS

Quantitative data synthesis was performed using a random-effects model with weighted mean difference (WMD) and 95% confidence interval (CI) as summary statistics.

RESULTS

In 30 studies (43 study arms) with 2953 participants, a significant increase in plasma adiponectin levels was observed after statin therapy (WMD: 0.57 μg/mL, 95% CI: 0.18, 0.95, p = 0.004). In subgroup analysis, atorvastatin, simvastatin, rosuvastatin, pravastatin and pitavastatin were found to change plasma adiponectin concentrations by 0.70 μg/mL (95% CI: -0.26, 1.65), 0.50 μg/mL (95% CI: -0.44, 1.45), -0.70 μg/mL (95% CI: -1.08, -0.33), 0.62 μg/mL (95% CI: -0.12, 1.35), and 0.51 μg/mL (95% CI: 0.30, 0.72), respectively. With respect to duration of treatment, there was a significant increase in the subset of trials lasting ≥12 weeks (WMD: 0.88 μg/mL, 95% CI: 0.19, 1.57, p = 0.012) but not in the subset of <12 weeks of duration (WMD: 0.18 μg/mL, 95% CI: -0.23, 0.58, p = 0.390). Random-effects meta-regression suggested a significant association between statin-induced elevation of plasma adiponectin and changes in plasma low density lipoprotein cholesterol levels (slope: 0.04; 95% CI: 0.01, 0.06; p = 0.002).

CONCLUSIONS

The meta-analysis showed a significant increase in plasma adiponectin levels following statin therapy. Although statins are known to increase the risk for new onset diabetes mellitus, our data might suggest that the mechanism for this is unlikely to be due to a reduction in adiponectin expression.

Для цитирования: Chruściel Piotr, Sahebkar Amirhossein, Rembek-Wieliczko Magdalena, Serban Maria-Corina, Ursoniu Sorin, Mikhailidis Dimitri P, Jones Steven R, Mosteoru Svetlana, Blaha Michael J, Martin Seth S, Rysz Jacek, Toth Peter P, Lip Gregory Y H, Pencina Michael J, Ray Kausik K, Banach Maciej, Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.. Atherosclerosis. 2016. DOI: 10.1016/j.atherosclerosis.2016.07.897.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.